NOT-OD-21-168: Notice to Extend Expiration Date and Add a Receipt Date for PA-18-932: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Notice to Extend Expiration Date and Add a Receipt Date for PA-18-932: Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Notice Number:

NOT-OD-21-168

Key Dates

Release Date:

August 5, 2021

Related Announcements

PA-18-932 - Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional)

Issued by

Division of Program Coordination, Planning and Strategic Initiatives, Office of Disease Prevention (ODP)

National Heart, Lung, and Blood Institute (NHLBI)

National Institute on Aging (NIA)

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

National Institute of Dental and Craniofacial Research (NIDCR)

National Institute on Drug Abuse (NIDA)

National Institute of Mental Health (NIMH)

National Institute on Minority Health and Health Disparities (NIMHD)

National Cancer Institute (NCI)

Purpose

The purpose of this Notice is to extend the expiration date for PA-18-932: “Increasing Uptake of Evidence-Based Screening in Diverse Adult Populations (R01 Clinical Trial Optional).” PA-18-932 will now expire on May 8, 2022.

The following section of the FOA has been changed:

Part 1. Overview Information, Key Dates

Currently Reads: Expiration Date January 8, 2022

Modified to Read (changes shown in italics): Expiration Date May 8, 2022

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Melissa C. Green Parker, PhD
Office of Disease Prevention (ODP)
Telephone: 301-480-1161
Email: [email protected]